Clinical trials have long been plagued by inefficiency, lack of diversity and the inability to leverage data. The pandemic increased the need to modernize trials, which pushed many trials to lean on technology to conduct trials remotely. Ben Leonard explains why money is pouring into the space and why many clinical trials are still stuck in the previous century.
Learn more about your ad choices. Visit megaphone.fm/adchoices
